Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action

Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action

Andrew W Lindsley,1 Njira Lugogo,2 Kaitlin AG Reeh,3 Joseph Spahn,3 Jane R Parnes1 1Amgen Inc., Thousand Oaks, CA, USA; 2Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USA; 3AstraZeneca, Gaithersburg, MD, USACorrespondence: Andrew W Lindsley, US Medical Affairs, Amgen Inc.,...

Full description

Bibliographic Details
Main Authors: Lindsley AW, Lugogo N, Reeh KAG, Spahn J, Parnes JR
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Journal of Asthma and Allergy
Subjects:
thymic stromal lymphopoietin
tslp
t2 inflammation
asthma
biologics
biomarker
anti-tslp
Online Access:https://www.dovepress.com/asthma-biologics-across-the-t2-spectrum-of-inflammation-in-severe-asth-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/asthma-biologics-across-the-t2-spectrum-of-inflammation-in-severe-asth-peer-reviewed-fulltext-article-JAA

Similar Items